{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:18:38Z","timestamp":1791389918364,"version":"4.3.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,11,5]],"date-time":"2016-11-05T00:00:00Z","timestamp":1478304000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s10067-016-3462-z","type":"journal-article","created":{"date-parts":[[2016,11,5]],"date-time":"2016-11-05T16:07:23Z","timestamp":1478362043000},"page":"457-461","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The conversion rate of tuberculosis screening tests during biological therapies in patients with rheumatoid arthritis"],"prefix":"10.1007","volume":"36","author":[{"given":"Giovanna","family":"Cuomo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"D\u2019Abrsca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Iacono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Pantano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,5]]},"reference":[{"issue":"9","key":"3462_CR1","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/383317","volume":"38","author":"RS Wallis","year":"2004","unstructured":"Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO (2004) Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 38(9):1261\u20131265","journal-title":"Clin Infect Dis"},{"issue":"8","key":"3462_CR2","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","volume":"48","author":"JJ G\u00f3mez-Reino","year":"2003","unstructured":"G\u00f3mez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD, BIOBADASER Group (2003) Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 48(8):2122\u20132127","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3462_CR3","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/art.21043","volume":"52","author":"L Carmona","year":"2005","unstructured":"Carmona L, G\u00f3mez-Reino JJ, Rodr\u00edguez-Valverde V, BIOBADASER Group et al (2005) Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum 52(6):1766\u20131772","journal-title":"Arthritis Rheum"},{"key":"3462_CR4","unstructured":"World Health Organization. Global tubercolosis report (2013) URL: http:\/\/apps.who.int\/iris\/bitstream\/10665\/91355\/1\/9789241564656_eng.pdf"},{"issue":"10","key":"3462_CR5","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1093\/rheumatology\/keu172","volume":"53","author":"A Souto","year":"2014","unstructured":"Souto A, Maneiro JR, Salgado E, Carmona L, Gomez-Reino JJ (2014) Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: a systematic review and meta-analysis of randomized controlled trials and long-term extension studies. Rheumatology (Oxford) 53(10):1872\u20131885. doi: 10.1093\/rheumatology\/keu172","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"3462_CR6","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/acr.21641","volume":"64","author":"JA Singh","year":"2012","unstructured":"Singh JA, Furst DE, Bharat A et al (2012) 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 64(5):625\u2013639. doi: 10.1002\/acr.21641","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"12","key":"3462_CR7","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1128\/CVI.05299-11","volume":"18","author":"D Vassilopoulos","year":"2011","unstructured":"Vassilopoulos D, Tsikrika S, Hatzara C et al (2011) Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy. Clin Vaccine Immunol 18(12):2102\u20132108. doi: 10.1128\/CVI.05299-11","journal-title":"Clin Vaccine Immunol"},{"issue":"7","key":"3462_CR8","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.3899\/jrheum.100623","volume":"38","author":"EC Keystone","year":"2011","unstructured":"Keystone EC, Papp KA, Wobeser W (2011) Challenges in diagnosing latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. J Rheumatol 38(7):1234\u20131243. doi: 10.3899\/jrheum.100623","journal-title":"J Rheumatol"},{"issue":"10","key":"3462_CR9","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.3899\/jrheum.090150","volume":"36","author":"JH Park","year":"2009","unstructured":"Park JH, Seo GY, Lee JS, Kim TH, Yoo DH (2009) Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial. J Rheumatol 36(10):2158\u20132163. doi: 10.3899\/jrheum.090150","journal-title":"J Rheumatol"},{"key":"3462_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3899\/jrheum.120252","volume":"89","author":"A Sanduzzi","year":"2012","unstructured":"Sanduzzi A, Bocchino M, Atteno M et al (2012) Screening and monitoring of latent tubercular infection in patients taking tumor necrosis factor-\u03b1 blockers for psoriatic arthritis. J Rheumatol Suppl 89:82\u201385. doi: 10.3899\/jrheum.120252","journal-title":"J Rheumatol Suppl"},{"issue":"10","key":"3462_CR11","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1136\/annrheumdis-2014-205376","volume":"74","author":"C Hatzara","year":"2015","unstructured":"Hatzara C, Hadziyannis E, Kandili A et al (2015) Frequent conversion of tuberculosis screening tests during anti-tumour necrosis factor therapy in patients with rheumatic diseases. Ann Rheum Dis 74(10):1848\u20131853. doi: 10.1136\/annrheumdis-2014-205376","journal-title":"Ann Rheum Dis"},{"key":"3462_CR12","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd (2010) Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569\u20132581","journal-title":"Arthritis Rheum"},{"key":"3462_CR13","first-page":"5221","volume":"161","author":"American Thoracic Society","year":"2000","unstructured":"American Thoracic Society (2000) Targeted tuberculin testing and treatment of latent tubercolosis infection. Am J Respir Crit Care Med 161:5221\u20135247","journal-title":"Am J Respir Crit Care Med"},{"issue":"RR-5","key":"3462_CR14","first-page":"1","volume":"59","author":"GH Mazurek","year":"2010","unstructured":"Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K, IGRA Expert Committee; Centers for Disease Control and Prevention (CDC) (2010) Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection\u2014United States, 2010. MMWR Recomm Rep 59(RR-5):1\u201325","journal-title":"MMWR Recomm Rep"},{"issue":"9","key":"3462_CR15","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1007\/s00296-011-2017-5","volume":"32","author":"CA Nobre","year":"2012","unstructured":"Nobre CA, Callado MR, Lima JR, Gomes KW, Martiniano GV, Vieira WP (2012) Tuberculosis infection in rheumatic patients with infliximab therapy: experience with 157 patients. Rheumatol Int 32(9):2769\u20132775. doi: 10.1007\/s00296-011-2017-5","journal-title":"Rheumatol Int"},{"issue":"2","key":"3462_CR16","first-page":"121","volume":"49","author":"CDL Marques","year":"2009","unstructured":"Marques CDL, Duarte ALBP, Lorena VMB et al (2009) Resposta atenuada ao PPD no diagnostico de infection tuberculosa latente em pacientes com artrite reumatoide. Rev Bras Reumatol 49(2):121\u2013131","journal-title":"Rev Bras Reumatol"},{"issue":"4","key":"3462_CR17","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/art.21734","volume":"54","author":"R Westhovens","year":"2006","unstructured":"Westhovens R, Yocum D, Han J, START Study Group et al (2006) The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities: a large, randomized, placebo-controlled trial. Arthritis Rheum 54(4):1075\u20131086","journal-title":"Arthritis Rheum"},{"issue":"2","key":"3462_CR18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1136\/annrheumdis-2011-200489","volume":"71","author":"DY Chen","year":"2012","unstructured":"Chen DY, Shen GH, Chen YM, Chen HH, Hsieh CW, Lan JL (2012) Biphasic emergence of active tuberculosis in rheumatoid arthritis patients receiving TNF\u03b1 inhibitors: the utility of IFN\u03b3 assay. Ann Rheum Dis 71(2):231\u2013237. doi: 10.1136\/annrheumdis-2011-200489","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"3462_CR19","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1111\/j.1468-3083.2011.04220.x","volume":"26","author":"S Garcovich","year":"2012","unstructured":"Garcovich S, Ruggeri A, D'Agostino M et al (2012) Clinical applicability of quantiferon-TB-gold testing in psoriasis patients during long-term anti-TNF-alpha treatment: a prospective, observational study. J Eur Acad Dermatol Venereol 26(12):1572\u20131576. doi: 10.1111\/j.1468-3083.2011.04220.x","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"3462_CR20","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/art.23705","volume":"59","author":"DY Chen","year":"2008","unstructured":"Chen DY, Shen GH, Hsieh TY, Hsieh CW, Lan JL (2008) Effectiveness of the combination of a whole-blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy. Arthritis Rheum 59(6):800\u2013806. doi: 10.1002\/art.23705","journal-title":"Arthritis Rheum"}],"updated-by":[{"DOI":"10.1007\/s10067-017-3614-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T00:00:00Z","timestamp":1490659200000}}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3462-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-016-3462-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3462-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T22:56:54Z","timestamp":1498345014000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-016-3462-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,5]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["3462"],"URL":"https:\/\/doi.org\/10.1007\/s10067-016-3462-z","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10067-017-3614-9","asserted-by":"object"}]},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,5]]}}}